Clinical Trials Logo

Urinary Bladder Neoplasms clinical trials

View clinical trials related to Urinary Bladder Neoplasms.

Filter by:

NCT ID: NCT05937555 Completed - Bladder Cancer Clinical Trials

Professional Bladder Cancers and the Profession of Painter

NEVPP
Start date: March 15, 2021
Phase:
Study type: Observational

This is a retrospective study on bladder cancer in French painters' population. The French agency ANSES collected data from all occupational and environmental diseases center in a specific database called RNV3P. We selected cases of bladder cancer in painters in four centers from 01/01/2010 to 31/12/2019. Those cases were analyzed in terms of occupational exposure, histology and sociodemographics data. Comparison between different histologic types of cancer, workplaces and occupational diseases process will be done.

NCT ID: NCT05822518 Completed - Cancer, Bladder Clinical Trials

Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the outcome of perioperative immune-nutrition with glutamine, arginine and fish oil in patients undergoing radical cystectomy as regards to enhancement of healing, increasing immunity and improving overall health status.

NCT ID: NCT05675176 Completed - Clinical trials for Non-muscle-invasive Bladder Cancer

Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer

Start date: April 12, 2020
Phase:
Study type: Observational

The study compares the complications caused after the BCG intravesical instillation in patients treated for non invasive bladder cancer.The patients are divided into two groups one receiving IVI (intravesical Instillations) with the use of latex catheter while in the other silicone catheter is used.The two groups are compared in terms of fever, hematuria, LUTS and other complications following IVI.

NCT ID: NCT05671289 Completed - Bladder Cancer Clinical Trials

Urine VOC Investigation in Bladder Cancer Diagnosis

Start date: November 10, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this study to investigate the volatile organic compounds (VOCs) in the urine samples of both healthy individual and bladder cancer patients, using gas chromatography - mass spectrometry. Researchers aim to find a set of certain VOCs specific to bladder cancer and use this set to construct a diagnostic model that can help diagnosing bladder cancer. Participants will be asked to collect their early morning midstream urine in a predesignated container. Researchers will compare urine VOCs from bladder cancer patients and healthy individuals to see if there is any VOC whose concentration differ significantly among the two groups.

NCT ID: NCT05600322 Completed - Bladder Cancer Clinical Trials

Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer

Start date: November 3, 2022
Phase: Phase 3
Study type: Interventional

A study to compare Hexvix Blue light cstoscopy with standard White light cystoscopy in the detection of bladder cancer.

NCT ID: NCT05540847 Completed - Bladder Neoplasm Clinical Trials

Comparison of Interfascial Injection Versus Subpectineal Injection on Ultrasound-guided Obturator Nerve Block

Start date: September 16, 2022
Phase: N/A
Study type: Interventional

This study aimed to assess the effectiveness of the ultrasound-guided interfascial injection approach with the subpectineal injection technique for obturator nerve block in bladder cancers undergoing transurethral resection of bladder tumor (TURBT) under spinal anesthesia.

NCT ID: NCT05376631 Completed - Bladder Cancer Clinical Trials

Effect of Fresh Gas Flow on Emergence Time

Start date: May 20, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of fresh gas flow on emergence time in patients undergoing transurethral resection of bladder tumor.

NCT ID: NCT05362539 Completed - Bladder Cancer Clinical Trials

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

The current study aimed to assess the diagnostic performance of novel urine-based DNA hypermethylation of six genes (GATA4, P16, P14, APC, CDH1 and CD99) for UBC detection in patients with hematuria.

NCT ID: NCT05324033 Completed - Cancer, Bladder Clinical Trials

Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

Start date: May 1, 2022
Phase:
Study type: Observational

Differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is a cornerstone in the treatment plans.Therefore, this study will try to evaluate the sensitivity and reliability of mpMRI in accurate diagnosis of cancer bladder. Primary objective: to detect the sensitivity of multiparametric MRI in differentiation between muscle Invasive and non-muscle invasive Urinary Bladder Cancer in relation to the conventional cystoscopy and histopathological examination of the biopsy.

NCT ID: NCT05314582 Completed - Hematuria Clinical Trials

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

Start date: March 10, 2022
Phase:
Study type: Observational [Patient Registry]

Patients who were using anticoagulant or antiaggregant medications for any reason and underwent transurethral resection of bladder tumor (TUR-BT) or transurethral resection of the prostate (TURP) or open prostatectomy (OP) due to BPH will be compared with those who were not using anticoagulant or antiplatelet medication. The rates of postoperative clot retention, presence of hematuria, reoperation due to hematuria, blood transfusion and re-admissions due to hematuria in the first postoperative month will be compared.